Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Synchronous Bilateral Breast Carcinoma”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02750826
What this trial is testing

Breast Cancer WEight Loss Study (BWEL Study)

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7+4 more
Alliance for Clinical Trials in Oncology 3,177
Large-scale testing (Phase 3)Active Not RecruitingNCT04457596
What this trial is testing

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2 Positive Breast Carcinoma+4 more
Alliance for Clinical Trials in Oncology 1,056
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018